Monitor for the announcement of the revised distribution and ex-dividend dates. The delay is administrative, not value-destructive, but introduces timing uncertainty for the spin-off. No immediate trading catalyst.
Price Chart
Executive Summary
ABVC BioPharma postponed the previously announced distribution of BioKey (Cayman) Inc. ordinary shares, which had been scheduled for August 3, 2026, citing the need for additional time to complete administrative, regulatory, and tax-related matters. The record date and distribution ratio (0.169464 BioKey shares per ABVC share) remain unchanged, but the ex-dividend date is voided pending a new distribution date. This is a routine administrative delay with no material financial impact disclosed, though it introduces uncertainty around the timing of the spin-off value realization for shareholders of this $27M market cap micro-cap.
Key Facts
- ABVC postponed the distribution of BioKey (Cayman) Inc. ordinary shares, originally scheduled for August 3, 2026.
- The distribution ratio remains 0.169464 BioKey shares per ABVC common share held as of the record date.
- The previously announced ex-dividend date no longer applies and will be revised.
- The record date remains unchanged.
- The company is coordinating with Nasdaq, DTC, and its transfer agent to establish updated dates.
Financial Impact
No financial figures disclosed; the distribution is a non-cash spin-off of BioKey shares. No revenue, earnings, or deal value reported.
Risk Factors
- Further delays in completing administrative, regulatory, or tax-related matters could push the distribution date out further.
- Uncertainty around the new ex-dividend date may create short-term confusion for shareholders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-084846 |
| Document: 0001213900-26-084846-index-headers.html | 0001213900-26-084846 |
| Document: 0001213900-26-084846-index.html | 0001213900-26-084846 |
| Document: 0001213900-26-084846.txt | 0001213900-26-084846 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | DEF 14A | $1.04 $0.9700 | ▲ +6.73% | ▲ +8.68% | $1.05 (−0.96%) |
Aug 3, 2026 12w ago | 8-K | $1.07 $0.9850 | ▼ −7.94% | ▼ −7.84% | $1.05 (−1.87%) |
Jul 2, 2026 16w ago | 8-K | $1.80 $1.45 | ▲ +19.44% | ▲ +20.37% | $1.05 (+41.67%) |
Mar 3, 2026 34w ago | 8-K | $1.45 $1.42 | ▲ +2.07% | ▲ +0.74% | $1.05 (+27.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers